Position in MRK
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$7,875,626
+$854,890 QoQ
Shares Held
65,472
-1.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Anchor Investment Management, LLC holds $69,112,010 across 15 Drug Manufacturers - General names. MRK ranks #4 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,612 | $21,415,877 | |
| 2 | ABBV |
AbbVie Inc.
|
87,821 | $19,100,189 | |
| 3 | LLY |
ELI LILLY & Co
|
13,180 | $12,122,568 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
65,472 | $7,875,626 | |
| 5 | PFE |
Pfizer Inc
|
87,568 | $2,458,909 | |
| 6 | GSK |
GSK plc
|
33,440 | $1,845,553 | |
| 7 | AMGN |
Amgen Inc
|
4,884 | $1,718,435 | |
| 8 | NVS |
Novartis AG
|
6,726 | $1,027,396 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,875,626 | 65,472 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $7,020,736 | 66,699 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $5,657,973 | 67,413 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,411,060 | 68,356 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $6,281,853 | 69,985 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $7,027,167 | 70,639 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,524,949 | 75,070 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $9,141,639 | 73,842 | Shares | Sole | 2024-09-20 | |
| 2024-03-31 | $9,985,052 | 75,673 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,469,000 | 77,683 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $7,950,828 | 77,230 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $8,736,523 | 75,713 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $7,954,993 | 74,772 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $8,385,046 | 75,575 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $6,680,672 | 77,574 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $7,041,788 | 77,238 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $6,334,095 | 77,198 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $5,734,817 | 74,828 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $4,718,259 | 62,818 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $4,653,756 | 59,840 | Shares | Sole | 2024-01-02 | |
| 2021-03-31 | $4,230,238 | 54,874 | Shares | Sole | 2024-01-02 | |
| 2020-12-31 | $2,703,488 | 33,050 | Shares | Sole | 2024-01-02 | |
| 2020-09-30 | $2,720,761 | 32,800 | Shares | Sole | 2024-01-02 | |
| 2020-06-30 | $2,512,916 | 32,496 | Shares | Sole | 2024-01-02 | |
| 2020-03-31 | $2,544,404 | 33,070 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||